CORONA Remedies to attend investor conference in London

0 min read     Updated on 10 Jun 2026, 09:22 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

CORONA Remedies Limited announced its participation in an investor conference in London on June 15-16, 2026, hosted by Kotak Institutional Equities. The event will feature 1x1 and group meetings based on publicly available information, with no disclosure of unpublished price sensitive information.

powered bylight_fuzz_icon
42609114

*this image is generated using AI for illustrative purposes only.

CORONA Remedies Limited will participate in an investor conference in London on June 15 and June 16, 2026, to engage with institutional investors. The meetings, organized by Kotak Institutional Equities, are scheduled to commence at 09:00 AM British Summer Time (BST) onwards. The company clarified that discussions during these sessions will be restricted to publicly available information, ensuring no unpublished price sensitive information (UPSI) is disclosed.

The conference will include both 1x1 meetings and group interactions. The disclosure was made to the stock exchanges in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Date and Time Organized by Nature of Conferences Place
June 15, 2026 and June 16, 2026
09:00 AM (BST) Onwards
Kotak Institutional
Equities
1x1 Meetings / Group London, United
Kingdom

CORONA Remedies noted that the schedule is subject to change due to exigencies on the part of the host or the company. The intimation has been made available on the company's official website.

Historical Stock Returns for Corona Remedies

1 Day5 Days1 Month6 Months1 Year5 Years
+2.68%+1.59%-1.57%+20.15%+20.15%+20.15%

What strategic outcomes does CORONA Remedies aim to achieve by engaging with institutional investors in London?

How might the investor conference influence the company's stock liquidity and visibility in international markets?

What potential partnerships or market expansions could be explored during these interactions?

CORONA Remedies promoter confirms no encumbrance on shares in FY26

1 min read     Updated on 04 Jun 2026, 09:30 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Dr. Kirtikumar Mehta, Promoter of CORONA Remedies Limited, confirmed in a filing to stock exchanges that he and Persons Acting in Concert have not encumbered any equity shares held directly or indirectly during FY26. The disclosure, dated April 01, 2026, was made under Regulation 31(4) of SEBI SAST Regulations and lists 23 individuals and entities in the promoter group.

powered bylight_fuzz_icon
42134413

*this image is generated using AI for illustrative purposes only.

Dr. Kirtikumar Mehta, Promoter of corona remedies , has declared that he and Persons Acting in Concert have not made any encumbrance on the equity shares held by them during the financial year 2025-2026. The disclosure, submitted to BSE Limited and National Stock Exchange of India Limited, confirms that the shares held directly or indirectly by the promoter group remain free of charges or liens. This filing was made pursuant to Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The declaration encompasses the promoter and the broader promoter group, including various individuals and entities listed as Persons Acting in Concert. The list includes family members such as Nirav Mehta and Ankur Mehta, as well as corporate entities like NKM Nextgen LLP and KLNext Enterprise LLP. The submission was addressed to the Department of Corporate Relations at BSE and the Department of Corporate Services at NSE on April 01, 2026.

Persons Acting in Concert

The following table details the individuals and entities covered under the declaration:

Sr. No. Name
Promoter
1. Nirav Mehta
2. Ankur Mehta
Promoter Group
3. Minaxi Kirtikumar Mehta
4. Deepa Nirav Mehta
5. Brinda Ankur Mehta
6. Hetvi Nirav Mehta
7. Vanshaj Niravkumar Mehta
8. Jitendrakumar Champaklal Vora
9. Chandrika Jitendrakumar Vora
10. Nehal Devang Vora
11. Heti Darshan Kothari
12. Vishwa Ankur Mehta
13. Jainam Ankur Mehta
14. Subodhbhai Vrajlal Parikh
15. Shardaben Subodhbhai Parikh
16. Pritesh Subodhbhai Parikh
17. Kanakben Arvindbhai Shah
18. Vasumatiben Kirtibhai Shah
19. Yogeshbhai Harilal Shah
20. Ketan Harilal Shah
21. Nemish Harilal Shah
22. NKM Nextgen LLP
23. KLNext Enterprise LLP

The declaration was signed by Dr. Kirtikumar Mehta, Chairman of CORONA Remedies Limited, and copies were forwarded to the Chairman of the Audit Committee and the Company Secretary and Compliance Officer.

Historical Stock Returns for Corona Remedies

1 Day5 Days1 Month6 Months1 Year5 Years
+2.68%+1.59%-1.57%+20.15%+20.15%+20.15%

Does the unencumbered status of promoter shares indicate a potential plan to raise capital through pledging in the future?

How might this clean shareholding structure influence investor confidence and stock liquidity in the upcoming fiscal year?

Could this declaration be a precursor to a strategic acquisition or a stake sale by the promoter group?

More News on Corona Remedies

1 Year Returns:+20.15%